Background: Non-uniform strut distribution (NSD) is an important factor predisposing to intimal hyperplasia through decreased local drug delivery and increased scaffold recoil after BVS implantation. The aim of this study was to evaluate, using optical coherence tomography (OCT), the impact of underlying plaque morphology on strut distribution of bioresorbable vascular scaffolds (BVS 1.1) versus metallic everolimus eluting stents (EES). Methods: Among 39 patients who underwent elective percutaneous coronary intervention (PCI) (n¼20 in BVS group, n¼19 in EES group), a total of 1200 post-PCI OCT frames (BVS: 590 frames; EES: 610 frames) were analyzed. NSD was defined as a frame with maximum inter-strut angle i 120
. was identified as an independent predictor of NSD after BVS implantation (odds ratio: 12.1, 95% confidence interval: 7.9-18.8, p< 0.001).
Conclusions:
The presence of calcified plaque behind BVS struts appears to be an independent predictor for NSD. For calcified lesions, meticulous lesion preparation, including use of dedicated devices, may help prevent NSD after BVS stent implantation.
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Clinical Propensity score (PS) matching was applied prior to comparisons between the two groups. Primary outcome was major adverse cardiac events (MACE) which was defined as all-cause death, follow-up myocardial infarction (MI) and target-vessel revascularization (TVR). Results: A total of 432 patients were included in this study. After PS matching, 96 patients treated with BVS (BVS group) and 96 patients treated with DES (DES group) were selected. Lesion characteristics were similar between two groups. Over 80% of lesions in both cohorts were ACC/AHA lesion classification type B2 and C (83.3% in BVS vs. 85.2% in DES, p¼0.68) . Pre and post-dilatation in BVS group were performed more frequently compared to that in DES group (100% vs. 72.1%, p< 0.01; 100% vs. 86.4%, p< 0.01), and maximum inflation pressure after stenting in BVS group was higher than that in DES group (21.1AE5.1 atm vs. 18.4AE5.1 atm, p< 0.01). There was no significant difference in the 1-year cumulative MACE incidence between the BVS and the DES group (10.8% vs. 12.7%, p¼0.33). Similarly there was no significant differences in the composite endpoint of all-cause death and MI (3.6% vs. 4.5%, p¼0.30), TVR (10.8% vs. 9.6%, p¼0.80) or target lesion revascularization (9.2% vs. 5.6%, p¼0.51). There was 1 episode of definite stent thrombosis in BVS group and 1 in EES group. Conclusions: In the present all-comers cohort with a high proportion of complex lesions, the 1-year MACE in the BVS group was similar to that of patients treated with new generation DES. In the BVS group, however, meticulous lesion preparation including dedicated balloons may be needed to achieve similar clinical outcomes. Background: While everolimus-eluting bioresorbable vascular scaffolds (BVS) were studied in healthy swine, effects of inflammation and atherosclerosis on degradation of BVS and vascular behaviour remain to be determined. Methods: Of 15 farm-bred swine, 8 received streptozotocin to induce diabetes mellitus (DM), then a high cholesterol diet was given to all 15 swine. Nine months later, 32 coronary Absorb BVS (Abbott Vascular, Santa Clara, CA) were implanted under angiographic guidance. Histology, serology and polymer degradation analysis was performed. Results of degradation were compared to controls from normal, nonatherosclerotic swine (n ¼ 6/ time point).
Results: Degradation was similar in diseased and normal healthy swine and was determined only by implanted duration. It was not affected by DM, lipid accumulation in the neointima, or inflammation (Fig) . Struts were completely covered at both 3 and 6 months follow-up, irrespective of DM and atherosclerosis. Likewise, DM did not affect histological scores. Importantly, all disease groups showed marked neointimal atherosclerosis, with focal lipid accumulation, irregular collagen distribution and neointimal calcifications. The latter was observed in various patterns, particularly towards the lumen.
Conclusions:
In swine coronary arteries, DM, atherosclerosis and inflammation do not affect BVS degradation or the vascular response to BVS. Both in DM and non-DM, the neointima was equally associated with calcification, lipid accumulation and inhomogeneous collagen deposition indicating early neo-atherosclerosis. 
